Back
MaxCyte Stock Predictions

Is the Traditional House Obsolete?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
20
MXCT
MaxCyte
Last Price:
$2.21
Seasonality Move:
51.27%
7 Day Trial
ALL ACCESS PASS
$
7

Your Portfolio's Boring. This Company Isn't And It's Early
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatioMaxCyte Stock Forecast
Will MaxCyte Stock Go Up Next Year?
Data Unavailable
MaxCyte Stock Rating
Data Unavailable
MaxCyte Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
maxcyte.com
52-Week Data
52-Week High:
5.26
52-Week Low:
2.10
Prediction Charts
Market Cap:
231.8M
Price in USD:
2.18
Volume:
3.7M
Beta:
0.34
Technical Analysis
SMA50:
2.72
SMA100:
3.48
SMA200:
3.69
52-Wk Change:
-54.11%
Stock Predictions
-
Is MaxCyte stock public?Yes, MaxCyte is a publicly traded company.
-
What is the MaxCyte stock quote today?The MaxCyte stock price is 2.18 USD today.
-
How to buy MaxCyte stock online?You can buy MaxCyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-1 | 2.85 | 2.79 | 2.88 | 2.76 |
May-2 | 2.83 | 2.82 | 2.88 | 2.80 |
May-5 | 2.79 | 2.67 | 2.80 | 2.65 |
May-6 | 2.64 | 2.66 | 2.77 | 2.60 |
May-7 | 2.69 | 2.74 | 2.86 | 2.66 |
May-8 | 2.45 | 2.43 | 2.74 | 2.40 |
May-9 | 2.43 | 2.36 | 2.43 | 2.29 |
May-12 | 2.42 | 2.27 | 2.47 | 2.23 |
May-13 | 2.29 | 2.20 | 2.31 | 2.19 |
May-14 | 2.19 | 2.20 | 2.25 | 2.14 |
May-15 | 2.19 | 2.23 | 2.23 | 2.10 |
May-16 | 2.23 | 2.30 | 2.33 | 2.23 |
May-19 | 2.26 | 2.28 | 2.31 | 2.24 |
May-20 | 2.25 | 2.18 | 2.28 | 2.16 |
MaxCyte Earnings
Data Unavailable
MaxCyte Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.04 per share, and an increase next year of $0.02 per share.
* MaxCyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.